SYS-CON MEDIA Authors: Lori MacVittie, RealWire News Distribution, Bob Gourley, Kevin Remde, Gathering Clouds

News Feed Item

Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect

DUBLIN, March 11, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect" market research report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

While autoinjectors are sometimes designed to work with a particular injectable product as a form of pharmaceutical branding, the typical autoinjector is designed to fit one or more standard sizes of prefilled disposable syringes. Until recently, autoinjectors were designed to be reused. The reason was that the injectors were too expensive to be successfully marketed as a throw-away device. Recent improvements in materials technology and device design have led to the creation of a class of autoinjectors that can be made economically in high production quantities, opening the door for the disposable autoinjector, and providing expanded opportunities for both patient and drug marketer.



Highlights

- Analyzes therapeutic demand drivers and evaluates commercial prefilled syringe products in eleven major therapeutic segments

- Analyzes design factors, material selection issues, technologies and market development issues

- Profiles injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations

- Charts market data and forecasts to 2018

For more information visit http://www.researchandmarkets.com/research/hnzxv6/autoinjectors_to  

Contact Details
Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Category: Healthcare and Medical Devices


SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.